Studies show that in pulmonary hypertension models, TGFBR2’s transcriptional activation under hypoxia is suppressed, and the interaction between its promoter and distal enhancer is weakened [24]. This evidence concerns the gene TGFBR2 and pulmonary arterial hypertension.